Santambrogio, P.; Cozzi, A.; Di Meo, I.; Cavestro, C.; Vergara, C.; RodrÃguez-Pascau, L.; Martinell, M.; Pizcueta, P.; Tiranti, V.; Levi, S.
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes. Pharmaceutics 2023, 15, 202.
https://doi.org/10.3390/pharmaceutics15010202
AMA Style
Santambrogio P, Cozzi A, Di Meo I, Cavestro C, Vergara C, RodrÃguez-Pascau L, Martinell M, Pizcueta P, Tiranti V, Levi S.
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes. Pharmaceutics. 2023; 15(1):202.
https://doi.org/10.3390/pharmaceutics15010202
Chicago/Turabian Style
Santambrogio, Paolo, Anna Cozzi, Ivano Di Meo, Chiara Cavestro, Cristina Vergara, Laura RodrÃguez-Pascau, Marc Martinell, Pilar Pizcueta, Valeria Tiranti, and Sonia Levi.
2023. "PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes" Pharmaceutics 15, no. 1: 202.
https://doi.org/10.3390/pharmaceutics15010202
APA Style
Santambrogio, P., Cozzi, A., Di Meo, I., Cavestro, C., Vergara, C., RodrÃguez-Pascau, L., Martinell, M., Pizcueta, P., Tiranti, V., & Levi, S.
(2023). PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes. Pharmaceutics, 15(1), 202.
https://doi.org/10.3390/pharmaceutics15010202
